• Vesna Celeva Markovska University Clinic for Eye Diseases Skopje, Faculty of Medicine, Ss. Cyril and Methodius University in Skopje, Republic of North Macedonia
  • Stefan Pandilov University Clinic for Eye Diseases Skopje, Republic of North Macedonia
  • Zoran Jovanov Public Health Institution General Hospital, Gevgelija, Republic of North Macedonia


A case of recurrent ocular toxoplasmosis, presented through diagnostic imaging techniques and laboratory tests. To show the course and development of the clinical picture of ocular toxoplasmosis in a 19-year-old girl with good visual acuity in both eyes, which was accidentally detected during a routine ophthalmological examination for a driver's license. At the University Clinic for Eye Diseases in Skopje, several imaging diagnostic methods have been performed, such as: fundus photography, aurofluorescence, optical coherence tomography (OCT) and fundus fluorescence angiography (FFA). Imaging techniques, along with laboratory tests for specific anti-toxoplasmosis IgG and IgM antibodies, have helped to diagnose this not-so-common entity-ocular toxoplasmosis. The development of the disease was followed by a clinical picture, certain diagnostic methods in a period of seven years. Three recurrences of the parasitosis occurred during that period. The third attack of toxoplasmosis was associated with the occurrence of measles in an otherwise healthy young woman, a possible trigger for reactivation of the disease. Regular laboratory tests of anti-toxoplasma IgG and IgM antibody titers were performed with the help of ELISA at PHI UC for infectious diseases and febrile conditions in Skopje, during the entire process of monitoring. The lesion described by the diagnostic modalities corresponded to the data obtained from the literature and together with the elevated values ​​of anti-toxoplasma IgG and IgM antibodies confirmed the diagnosis of congenital ocular toxoplasmosis.

Keywords: toxoplasmosis, ocular toxoplasmosis, therapy, laboratory tests, FFA, OCT



1. Dubey JP. History of the discovery of the life cycle of Toxoplasma gondii. Int J Parasitol. 2009 Jul 1;39(8):877-82. doi: 10.1016/j.ijpara.2009.01.005. PMID: 19630138.
2.C ampbell RSF, Mackay JMK, Vantsis JT, Canine Toxoplasmosis the Isolation of Toxoplasma Gondii from a Dog, Journal of Comparative Pathology and Therapeutics, Volume 68, 1958, Pages 96-IN9, ISSN 0368-1742,
3. Holland GN. Ocular toxoplasmosis: a global reassessment. Part I: epidemiology and course of disease. Am J Ophthalmol. 2003 Dec;136(6):973-88. doi: 10.1016/j.ajo.2003.09.040. PMID: 14644206.
4. Pleyer U, Schlüter D, Mänz M. Ocular toxoplasmosis: recent aspects of pathophysiology and clinical implications. Ophthalmic Res. 2014;52(3):116-23. doi: 10.1159/000363141. Epub 2014 Sep 19. PMID: 25248050.
5. Feustel SM, Meissner M, Liesenfeld O. Toxoplasma gondii and the blood-brain barrier. Virulence. 2012 Mar-Apr;3(2):182-92. doi: 10.4161/viru.19004. Epub 2012 Mar 1. PMID: 22460645; PMCID: PMC3396697.
6Montoya JG, Liesenfeld O. Toxoplasmosis. Lancet. 2004 Jun 12;363(9425):1965-76. doi: 10.1016/S0140-6736(04)16412-X. PMID: 15194258.
7. Perkins ES. Ocular toxoplasmosis. Br J Ophthalmol. 1973 Jan;57(1):1-17. doi: 10.1136/bjo.57.1.1. PMID: 4574554; PMCID: PMC1214816.
8. Glasner PD, Silveira C, Kruszon-Moran D, Martins MC, Burnier Júnior M, Silveira S, Camargo ME, Nussenblatt RB, Kaslow RA, Belfort Júnior R. An unusually high prevalence of ocular toxoplasmosis in southern Brazil. Am J Ophthalmol. 1992 Aug 15;114(2):136-44. doi: 10.1016/s0002-9394(14)73976-5. PMID: 1642287.
9. Delair E, Latkany P, Noble AG, Rabiah P, McLeod R, Brézin A. Clinical manifestations of ocular toxoplasmosis. Ocul Immunol Inflamm. 2011 Apr;19(2):91-102. doi: 10.3109/09273948.2011.564068. PMID: 21428746.
10. Bosch-Driessen LE, Berendschot TT, Ongkosuwito JV, Rothova A. Ocular toxoplasmosis: clinical features and prognosis of 154 patients. Ophthalmology. 2002 May;109(5):869-78. doi: 10.1016/s0161-6420(02)00990-9. PMID: 11986090.
11.Smith JR, Cunningham ET Jr. Atypical presentations of ocular toxoplasmosis. Curr Opin Ophthalmol. 2002 Dec;13(6):387-92. doi: 10.1097/00055735-200212000-00008. PMID: 12441842.
12. Rudich DS, Bhatnagar P. Scleritis associated with toxoplasmic retinochoroiditis. Arch Ophthalmol. 2012 May;130(5):659-60. doi: 10.1001/archophthalmol.2011.1527. PMID: 22652859.
13. Fish RH, Hoskins JC, Kline LB. Toxoplasmosis neuroretinitis. Ophthalmology. 1993 Aug;100(8):1177-82. doi: 10.1016/s0161-6420(13)31511-5. PMID: 8341498.
14. de Souza EC, Casella AM. Clinical and tomographic features of macular punctate outer retinal toxoplasmosis. Arch Ophthalmol. 2009 Oct;127(10):1390-4. doi: 10.1001/archophthalmol.2009.251. PMID: 19822862.
15. Adan A, Giralt J, Alvarez G, Alforja S, Burés-Jesltrup A, Casaroli-Marano RP, Corcostegui B. Pars plana vitrectomy for vitreoretinal complications of ocular toxoplasmosis. Eur J Ophthalmol. 2009 Nov-Dec;19(6):1039-43. PMID: 19882570.
16. Sousa DC, Andrade GC, Nascimento H, Maia A, Muccioli C. MACULAR HOLE ASSOCIATED WITH TOXOPLASMOSIS: A SURGICAL CASE SERIES. Retin Cases Brief Rep. 2021 Mar 1;15(2):110-113. doi: 10.1097/ICB.0000000000000757. PMID: 29975259.
17. Kahloun R, Mbarek S, Khairallah-Ksiaa I, Jelliti B, Yahia SB, Khairallah M. Branch retinal artery occlusion associated with posterior uveitis. J Ophthalmic Inflamm Infect. 2013 Jan 21;3(1):16. doi: 10.1186/1869-5760-3-16. PMID: 23514435; PMCID: PMC3605076.
18. Kalogeropoulos D, Sakkas H, Mohammed B, Vartholomatos G, Malamos K, Sreekantam S, Kanavaros P, Kalogeropoulos C. Ocular toxoplasmosis: a review of the current diagnostic and therapeutic approaches. Int Ophthalmol. 2022 Jan;42(1):295-321. doi: 10.1007/s10792-021-01994-9. Epub 2021 Aug 9. PMID: 34370174; PMCID: PMC8351587.
19. Maenz M, Schlüter D, Liesenfeld O, Schares G, Gross U, Pleyer U. Ocular toxoplasmosis past, present and new aspects of an old disease. Prog Retin Eye Res. 2014 Mar;39:77-106. doi: 10.1016/j.preteyeres.2013.12.005. Epub 2014 Jan 9. PMID: 24412517.
20.WILDER HC. Toxoplasma chorioretinitis in adults. AMA Arch Ophthalmol. 1952 Aug;48(2):127-36. doi: 10.1001/archopht.1952.00920010132001. PMID: 14943320.
21. Holland GN, Lewis KG. An update on current practices in the management of ocular toxoplasmosis. Am J Ophthalmol. 2002 Jul;134(1):102-14. doi: 10.1016/s0002-9394(02)01526-x. Erratum in: Am J Ophthalmol 2002 Dec;134(6):944. PMID: 12095816.
22. Opremcak EM, Scales DK, Sharpe MR. Trimethoprim-sulfamethoxazole therapy for ocular toxoplasmosis. Ophthalmology. 1992 Jun;99(6):920-5. doi: 10.1016/s0161-6420(92)31873-1. PMID: 1630782.
23. Matias M, Gomes A, Marques T, Fonseca AC. Ocular toxoplasmosis: a very rare presentation in an immunocompetent patient. BMJ Case Rep. 2014 Sep 30;2014:bcr2014205846. doi: 10.1136/bcr-2014-205846. PMID: 25270156; PMCID: PMC4180574.
24. De-la-Torre A, Gómez-Marín J. Disease of the Year 2019: Ocular Toxoplasmosis in HIV-infected Patients. Ocul Immunol Inflamm. 2020 Oct 2;28(7):1031-1039. doi: 10.1080/09273948.2020.1735450. Epub 2020 Mar 12. PMID: 32162993.
How to Cite
MARKOVSKA, Vesna Celeva; PANDILOV, Stefan; JOVANOV, Zoran. CASE REPORT: REACTIVATION OF CONGENITAL OCULAR TOXOPLASMOSIS IN AN IMMUNOCOMPETENT PATIENT AFTER RECEIVING MEASLES. Journal of Morphological Sciences, [S.l.], v. 5, n. 2, p. 43-51, aug. 2022. ISSN 2545-4706. Available at: <>. Date accessed: 02 apr. 2023.